Laser treatment for lowering eye pressure in Black patients with glaucoma
Part of Eyes & vision clinical trials.
This trial tests a laser procedure called DSLT to reduce eye pressure in Black patients with mild to moderate open-angle glaucoma. It aims to see if this treatment works well as a first step before using eye drops.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are of Black African descent.
- You have been diagnosed with mild to moderate open-angle glaucoma.
- You have not had any prior glaucoma surgeries or laser treatments.
- Your eye pressure is between 21 and 32 mm Hg without using pressure-lowering eye drops.
- You do not have other eye conditions (like advanced cataracts or retinal disease) or secondary glaucoma.
- You are not pregnant, breastfeeding, or planning to become pregnant during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new laser treatment called DSLT for people who have just been diagnosed with open-angle glaucoma or a similar condition like ocular hypertension. It aims to see if the laser can lower eye pressure by at least 20% after six months without needing any eye drops.
This study tests a newer type of laser treatment for glaucoma, called direct selective laser trabeculoplasty (DSLT), in people who have already had a standard SLT laser before. It aims to see if DSLT can further lower eye pressure, which may help protect your vision.
This trial tests a new laser treatment called DSLT for people with normal-tension glaucoma, a type of glaucoma where eye pressure is normal but vision is still damaged. It aims to lower eye pressure and help preserve vision. The study is specifically for people of Asian descent.
This trial tests a special laser treatment called Direct Selective Laser Trabeculoplasty (DSLT) for people with pseudoexfoliation glaucoma, a type of glaucoma that can be harder to treat. The treatment aims to lower eye pressure and may help delay or avoid the need for daily eye drops.
This trial tests a laser treatment called DSLT in people recently diagnosed with open-angle glaucoma who have never had any other glaucoma treatment. It aims to see how well the laser lowers eye pressure.
This trial tests a laser treatment called DSLT to see how it affects eye pressure changes over 6 months. It may help people with open-angle glaucoma or high eye pressure who are currently using 0 to 3 types of pressure-lowering eye drops.
Hear when a new Primary Open Angle Glaucoma (POAG) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.